Rotarix vaccine oral syringe 1.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FZ0Q3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,445
Award facts
- Contract value 100% obligated
- $1,445.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,445.08 to AmerisourceBergen Drug Corp for ROTARIX Vaccine Oral Syringe 1.5ML, a rotavirus vaccine product. The contract, executed on January 7, 2026, with completion targeted for January 8, 2026, utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. That IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and other critical medical commodities to support military healthcare programs worldwide. The contractor's consistent track record of fulfilling federal medical procurement requirements demonstrates its capability to meet the Defense Health Agency's vaccine supply needs across its service portfolio.
Quick answers
Who was awarded contract SPE2DR26FZ0Q3?
SPE2DR26FZ0Q3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FZ0Q3 worth?
The government has obligated $1,445 on SPE2DR26FZ0Q3.
Is contract SPE2DR26FZ0Q3 an order under another contract?
Yes. SPE2DR26FZ0Q3 is a delivery order under SPE2DR25D2018, an indefinite delivery contract.
Was contract SPE2DR26FZ0Q3 competed?
The extent of competition for SPE2DR26FZ0Q3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award